Duration: (3:32) ?Subscribe5835 2025-02-22T21:18:36+00:00
Infliximab and risk of serious infection in patients with psoriasis, Z.Z.N. Yiu et al
(3:32)
Infliximab and Adalimumab Explained
(10:45)
Infliximab - Anti-Autoimmune, Mechanism of Action
(27)
Infliximab Therapy for Pediatric IBD Patients - IBD in the News
(4:33)
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
(5:36)
Infliximab versus vedolizumab in treating immune-mediated diarrhea and colitis
(1:57)
Proactive Monitoring and Infliximab - IBD in the News
(4:36)
Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum
(4:53)
Discontinuation of Infliximab \u0026 Risk of Relapse in Patients W/Complete Remission of Crohn’s Disease
(5:39)
Infliximab for Patients with Severe Ulcerative Colitis - IBD in the News
(3:21)
Infliximab (Remicade) - Uses, Dosing, Side Effects | Pharmacist Review
(3:44)
Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence
(5:)
Infliximab (Remicade, Inflectra, Renflexis, Remsima) - IBD treatments explained by the experts
(9:41)
Using point of care testing for infliximab and fecal calprotectin in IBD patients with secondary LOR
(2:45)
FDA Approves of Biosimilar to Infliximab – IBD in the News
(6:18)
Individual variability in infliximab levels – Diane R. Mould, PhD
(2:9)
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
(4:52)
Can Originator Infliximab Pricing Remain Competitive in Treating Inflammatory Bowel Disease?
(15:)
Best of the Day: ACG2016 - Rapid Infliximab Infusion \u0026 Updated Models of Care
(11:6)